They argued however that the case “more than satisfies the usual standard for a GVR, and there is substantial reason to expect that a proper application of Taamneh will lead the lower courts to dismiss the complaint on remand.”
Representatives for the pharmaceutical companies and the servicemembers did not immediately respond to requests for comment on Tuesday.
AstraZeneca UK Ltd. and its affiliates are represented by Paul S. Mishkin, David B. Toscano, and Craig T. Cagney of Davis Polk & Wardwell LLP.
GE Healthcare USA Holding LLC and its affiliates are represented by John B. Bellinger III, David J. Weiner, and Robert Reeves Anderson of Arnold & Porter.
Johnson & Johnson, its affiliates, and Ortho Biologics LLC are represented by Kannon K. Shanmugam, Jeh C. Johnson, and Jessica S. Carey of Paul Weiss Rifkind Wharton & Garrison LLP.
Pfizer is represented by Lisa S. Blatt, Christopher N. Manning, Melissa B. Collins, Sarah M. Harris, and Aaron Z. Roper of Williams & Connolly LLP.
